A5049404104- Cardiac Arrest and Resuscitation
- Anesthesia and Sedative Agents
- Intensive Care Unit Cognitive Disorders
- Intramuscular injections and effects
- Antibiotic Resistance in Bacteria
- Platelet Disorders and Treatments
- Antibiotics Pharmacokinetics and Efficacy
- Sepsis Diagnosis and Treatment
- Pneumonia and Respiratory Infections
- Heparin-Induced Thrombocytopenia and Thrombosis
- Respiratory Support and Mechanisms
- Traumatic Brain Injury and Neurovascular Disturbances
- Pharmacological Receptor Mechanisms and Effects
- Drug-Induced Ocular Toxicity
- Thermal Regulation in Medicine
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- COVID-19 Clinical Research Studies
- Diabetes Management and Research
- Anesthesia and Pain Management
- Treatment of Major Depression
- Hemodynamic Monitoring and Therapy
- CNS Lymphoma Diagnosis and Treatment
- Family and Patient Care in Intensive Care Units
- Venous Thromboembolism Diagnosis and Management
Lee Memorial Hospital
2021-2022
Lee Memorial Health System
2013-2020
Clinical Physiology Associates
2018-2019
Mayo Clinic in Arizona
2012-2014
Despite the increasing incidence of carbapenem-intermediate or -resistant Enterobacteriaceae (CIRE), risk factors associated with CIRE infections have not been well defined. This study characterizes among two different source populations.A case-control was performed at a tertiary care medical centre between January 2005 and December 2009. Cases were adults culture-confirmed infection reduced susceptibility to meropenem ertapenem. The cases matched 1:1 patients from control series: (i) those...
Critical Care Medicine: January 2020 - Volume 48 Issue 1 p 441 doi: 10.1097/01.ccm.0000633232.77165.17
Critical Care Medicine: December 2015 - Volume 43 Issue 12 p 145 doi: 10.1097/01.ccm.0000474404.62728.2d
Critical Care Medicine: December 2015 - Volume 43 Issue 12 p 148 doi: 10.1097/01.ccm.0000474413.16093.cd
Introduction: Fluid resuscitation to a central venous pressure (CVP) goal of ≥ 8 is key component in the early management septic shock; however, there are no specific recommendations that address amount fluids and duration time patients must be maintained at targeted CVP goal. The purpose this study was determine if meeting target during first six hours severe sepsis shock treatment had an impact on 28-day mortality. Methods: A single-center retrospective cohort analysis critically ill...
Copyright © 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Critical Care Medicine: January 2020 - Volume 48 Issue 1 p 842 doi: 10.1097/01.ccm.0000649240.59638.26
Copyright © 2016 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Copyright © 2016 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Introduction: Given the multitude of thrombocytopenia etiologies in critically ill patients, diagnosis heparin-induced (HIT) intensive care unit (ICU) is often difficult to make. The purpose this study determine if a modified scoring system impacts diagnostic accuracy. Hypothesis: We hypothesized that 3T (m3T) system, which omits clinical evaluation other thrombocytopenic etiologies, as effective for HIT ICU when compared 4T score. Methods: This was retrospective cohort analysis adults who...
Copyright © 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Critical Care Medicine: January 2020 - Volume 48 Issue 1 p 723 doi: 10.1097/01.ccm.0000645888.86937.bf
1Lee Memorial Hospital, Fort Myers, Florida 2Fort FL 3Lee County Department of Public Safety,
Critical Care Medicine: January 2021 - Volume 49 Issue 1 p 212 doi: 10.1097/01.ccm.0000727668.56809.de
Introduction: Acute respiratory distress syndrome (ARDS) develops in approximately 33% of hospitalized coronavirus disease 19 (COVID-19) patients with 75% COVID-19-related intensive care unit (ICU) admissions caused by an ARDS diagnosis. Currently, there is conflicting evidence regarding the mortality benefit early neuromuscular blocking agents (NMBAs) being used moderate-to-severe ARDS, and data especially lacking despite increased NMBA utilization. This study aims to assess if versus late...
Critical Care Medicine: January 2022 - Volume 50 Issue 1 p 116 doi: 10.1097/01.ccm.0000807372.41729.d5
Critical Care Medicine: January 2022 - Volume 50 Issue 1 p 112 doi: 10.1097/01.ccm.0000807340.61508.78